RSSBiotech Stocks

Biotech Penny Stocks Investing Guide

Biotech Penny Stocks Investing Guide

| June 23, 2022

So, investing in penny stocks is difficult and nuanced. But, when we look at biotech penny stocks, we see that there are some key differences. For one, biotech penny stocks happen to be much more volatile than non-biotech penny stocks. This has to do with the nature of the industry and the amount of news […]

Continue Reading

7 Biotech Stocks With Key Catalysts For May

7 Biotech Stocks With Key Catalysts For May

| May 12, 2022

Biotech stocks are languishing close to their early 2020 bottom that they’d dropped to immediately after the onset of the Covid-19 pandemic. The sector was once considered as a better bet for those investors taking flight away from risky assets in times of uncertainty. Thus, the defensive appeal has been waning. Food and Drug Administration […]

Continue Reading

AXSM News: Why Axsome Therapeutics Stock Is Skyrocketing

AXSM News: Why Axsome Therapeutics Stock Is Skyrocketing

| January 8, 2019

Axsome Therapeutics (NASDAQ:AXSM) stock was flying high on Monday following some good AXSM news. The new bit of AXSM news from the company that has Axsome Therapeutics stock on the rise today has to do with recent results from a study. This comes from a Phase 2 trial of using its AXS-05 to treat major depressive disorder. The Phase […]

Continue Reading

4 Strong Buy Biotech Stocks With Upcoming FDA Decisions

4 Strong Buy Biotech Stocks With Upcoming FDA Decisions

| October 25, 2018

It’s crunch time. These 4 biotechs have what it takes to score crucial regulatory approvals Biotech stocks live and die by FDA decisions. Shares can soar or plunge depending on the FDA decision. Even an approval can spark a selloff if it’s not what investors expect. All four biotech stocks below have a fast-approaching PDUFA date. […]

Continue Reading

Fortress Biotech: A Unique Company Aiming To Make A Big Impact In Medicine

Fortress Biotech: A Unique Company Aiming To Make A Big Impact In Medicine

| October 11, 2018

Note: This is a review of Fortress Biotech as a company. Do your own research before making any investment decisions. The biopharmaceutical industry is at the forefront of developing the healthcare solutions of tomorrow. One interesting company, Fortress Biotech (FBIO), has taken a unique and different approach to drug discovery and drug development. Fortress Biotech’s business model […]

Continue Reading

7 Cheap Biotech Stocks To Buy Now

7 Cheap Biotech Stocks To Buy Now

| August 28, 2018

These biotech stocks are set for a strong comeback as investors walk away from large-cap tech companies U.S equities largely treaded water on Wednesday as Wall Street reacted to legal events and President Trump’s somewhat muted reaction to them. Elsewhere, strong earnings out of the retail sector are helping boost sentiment. The release of the […]

Continue Reading

5 Clinical-Stage Biotech Stocks To Buy Under $10

5 Clinical-Stage Biotech Stocks To Buy Under $10

| May 31, 2018

Clinical-stage biotech stocks offer plenty of promise to investors looking to take on some risk Not many sectors offer the potential for big time gains like biotech. Especially when you’re looking at smaller clinical-stage names. After all, the thrill of getting a big-time approval or even making through to the next round of FDA trial […]

Continue Reading

5 Big Biotech Stocks To Buy Under $10

5 Big Biotech Stocks To Buy Under $10

| March 22, 2018

Small biotech stocks can pack a wallop For investors, biotech stocks remain one of the most dynamic sectors out there. On one hand, you have some of the largest pharmaceutical firms on the planet with multi-billion-dollar blockbuster drugs filling their coffers. On the other, you have the more stereotypical “lotto ticket” biotech stocks of clinical […]

Continue Reading

4 Triple-Digit Winners In Biotech

4 Triple-Digit Winners In Biotech

| April 25, 2017

With important catalysts coming up in 2017, these stocks could soon become triple-digit winners in your portfolio. Start building a well-diversified biotech portfolio with these four stocks.  The overall biotech sector continues to be locked in a tight trading range, especially for such a high beta sector of the market. First quarter earnings reports for […]

Continue Reading

3 Undervalued Stocks On The Verge Of A Breakout

3 Undervalued Stocks On The Verge Of A Breakout

| April 6, 2017

Buying shares at these prices might look like a gift in six month’s time. With multiple catalysts to fuel share price growth on the horizon and a lot of good news not yet baked into the share price, now is a great time to get in.  The fairy tale story for biotech investors is buying […]

Continue Reading

3 Small Biotech Moonshots To Add To Your Portfolio

3 Small Biotech Moonshots To Add To Your Portfolio

| March 16, 2017

As the biotech sector heats up more in 2017, small stocks like the three in this article have already turned in some stellar performances. With the entire sector gaining steam, there’s still plenty of upside left. Bret Jensen recommends adding these three stocks to the portfolio.  Sentiment on the biotech sector early in 2017 sure has […]

Continue Reading